A SECOND drug to tackle Alzheimer’s disease could be on the horizon, research shows.
Trials of the medicine donanemab found it can successfully break down clumps of a protein called amyloid in the brain.
1 The new medicine has been found to be able to break down clumps of protein in the brain Cred